Table 2.
Effect of CDK deletions on mouse development.
Deletion | Phenotype | Reference |
---|---|---|
Cdk1 | Embryonic lethality during first cell divisions | Santamaria et al. (2007) |
Cdk2 | Reduced body size, impaired neural progenitor cell proliferation, infertility in males and females | Berthet et al. (2003), Ortega et al. (2003) |
Cdk3 | Viable and fertile | Ye et al. (2001) |
Cdk4 | Reduced body size, insulin deficient diabetes, infertility in males and females | Rane et al. (1999), Tsutsui et al. (1999) |
Cdk5 | Death at birth, severe neurological defects | Ohshima et al. (1996) |
Cdk6 | Fertile hypoplasia of thymus and spleen, defects in hematopoiesis | Malumbres et al. (2004) |
Cdk4 + Cdk6 | Lethality between embryonic day E14.5 and birth. Defective hematopoiesis, MEFs are viable | Malumbres et al. (2004) |
Cdk2 + Cdk4 | Lethality between E14.5 and E16.5, cardiac and hematopoietic abnormalities | Berthet et al. (2006) |
Cdk2 + Cdk6 | Infertility in males and females, defective hematopoiesis | Malumbres et al. (2004) |
Cdk2 + Cdk4 + Cdk6 | Lethality by E13.5 due to hematopoietic defects. MEFs proliferate slowly, but become immortal | Santamaria et al. (2007) |